Insights On Pharmaceutical Production

  1. A Solution To Automate Concentration, Washing, And Medium Exchange 3/27/2024

    Experience the assurance and peace of mind that come from utilizing a solution crafted to support the optimization and reliability of your operations.

  2. UPLC Columns: Fundamentals, Chemistries, And Selected Small-Molecule Applications 10/11/2024

    Discover the fundamentals of UPLC columns and their diverse chemistries. Learn more about versatility in separating small-molecule analytes using reversed-phase and hydrophilic interaction techniques.

  3. Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective 2/18/2025

    Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.

  4. HyPerforma DS 300 Single-Use Mixer Overview 11/10/2025

    Watch this video to learn more about the Thermo Scientific HyPerforma Single-Use Mixer DS 300. This Modular mixing system offers a cost-effective, docking station-style mixing platform with multiple mixing-volume options.

  5. When Measuring Filter Performance, Is Performance Absolute? 7/3/2024

    See why high-performing filters are inadequate for critical filtration processes and why sterilizing-grade filters are necessary to effectively remove undesirable species, including bacteria and viruses.

  6. Accelerated API Manufacturing: Combining All Process Development Stages 5/16/2024

    During early-stage development, utilize the key considerations outlined in this paper to avoid common pitfalls and expedite the transition from molecule to market.

  7. Experience The Future Of Bioseparations 4/16/2024

    Learn about an HPLC System designed to improve outcomes in QC labs with ease of use and simplicity at its core.

  8. Reliable Proliferation And Differentiation Of Desired T Cell Subpopulations 10/28/2024

    This study evaluates a cost-effective alternative to Proleukin® for expanding T cells that demonstrates comparable performance across cell viability, subpopulation ratios, and clinical consistency.

  9. Driving Seamless Tech Transfer Of Multiple Projects Within A Short Timeline 9/4/2025

    Uncover how we were able to provide seamless technology transfers and uninterrupted production to deliver critical therapies efficiently and reliably to patients.

  10. Optimize mAb Process Development To Reach Your Goals Quickly 5/6/2025

    In the pursuit of making your mAb process as efficient as possible, it is vital to identify the cell line, media, feed, and resin that best suit your productivity goals.